Clear Street’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1
Closed -$9 1449
2023
Q2
$9 Buy
+1
New +$10 ﹤0.01% 1293
2022
Q4
Sell
-724
Closed -$7K 1351
2022
Q3
$7K Buy
+724
New +$7.13K ﹤0.01% 714

Clear Street's MTACU Position: Q3 2023 in Review

Clear Street sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2023, closing a stake of 1 share — an estimated $9 sold.

Clear Street first reported a position in MTACU in Q3 2022 and held it in 2 quarters. The position peaked at $7K in Q3 2022. 0 funds tracked by Wall St. Rank hold MTACU as of Q3 2023.

  • Clear Street reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2023 after selling out during the quarter.
  • Clear Street sold 1 MedTech Acquisition Corporation Unit share in Q3 2023, an estimated $9.
  • Clear Street first reported a position in MedTech Acquisition Corporation Unit in Q3 2022 and held it in 2 quarters.
  • Clear Street's MedTech Acquisition Corporation Unit position peaked at $7K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2023.

Based on Clear Street's 13F filing for Q3 2023, filed 13 Nov 2023.